Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Pediatr (Phila) ; 58(13): 1409-1414, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31142142

RESUMEN

This article determines the prevalence of obesity among high school football players nationwide and compares obesity between position groups of football players and across team sports. We calculate body mass index (BMI) for 391 212 males participating in baseball, basketball, football, lacrosse, and soccer, then stratify BMI into commonly accepted categories and subdivide football players by position played, comparing BMI across position groups and sports. A total of 47.4% of high school football players are healthy weight (BMI = 18.5-24.9 kg/m2), 18.0% have obesity (BMI = 30-34.9 kg/m2: 12.4%) or class 2 obesity (BMI >34.9 kg/m2: 5.6%). Among linemen, 14.8% are healthy weight, 14.6% have class 2 obesity, and another 29.3% have obesity. Among non-linemen, the combined prevalence of obesity and class 2 obesity is 2.7%, comparable to other team sports. Obesity is common among high school football players, more so than among other high school athletes. Obesity and class 2 obesity are only common among linemen.


Asunto(s)
Atletas/estadística & datos numéricos , Fútbol Americano/estadística & datos numéricos , Obesidad Infantil/epidemiología , Adolescente , Índice de Masa Corporal , Humanos , Masculino , Prevalencia , Deportes/estadística & datos numéricos , Estados Unidos/epidemiología
2.
Hematology Am Soc Hematol Educ Program ; 2018(1): 412-417, 2018 11 30.
Artículo en Inglés | MEDLINE | ID: mdl-30504340

RESUMEN

Traditionally, the athlete who requires long-term anticoagulation has been told to forgo participation in contact and collision sports. However, a strategy of short-term interruption of anticoagulant therapy may be designed for some athletes, allowing them return to full athletic activity. A personalized pharmacokinetic/pharmacodynamic study of a direct oral anticoagulant (DOAC) may allow athletic participation when plasma drug concentration is minimal and resumption of treatment after the risk of bleeding sufficiently normalizes. Scientific data and uncertainties regarding this approach, as well as practical challenges in the implementation, will be discussed.


Asunto(s)
Anticoagulantes , Monitoreo de Drogas/métodos , Medicina Deportiva/métodos , Administración Oral , Anticoagulantes/efectos adversos , Anticoagulantes/farmacocinética , Anticoagulantes/uso terapéutico , Atletas , Femenino , Hemorragia/sangre , Hemorragia/inducido químicamente , Hemorragia/prevención & control , Humanos , Masculino , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA